ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,580 | -92.2% | 56,987 | -90.5% | 0.00% | -100.0% |
| Q2 2023 | $4,007,058 | -28.5% | 597,177 | -6.0% | 0.00% | -33.3% |
| Q1 2023 | $5,607,606 | +17.9% | 635,063 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $4,757,565 | +2.2% | 622,718 | -4.8% | 0.00% | 0.0% |
| Q3 2022 | $4,657,000 | -11.2% | 654,053 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $5,246,000 | +10.7% | 648,402 | +89.9% | 0.00% | +50.0% |
| Q1 2022 | $4,739,000 | +25.1% | 341,420 | +152.9% | 0.00% | 0.0% |
| Q4 2021 | $3,788,000 | -29.0% | 134,999 | -14.0% | 0.00% | -33.3% |
| Q3 2021 | $5,337,000 | -10.6% | 157,011 | +7.5% | 0.00% | 0.0% |
| Q2 2021 | $5,969,000 | -10.0% | 146,089 | -11.4% | 0.00% | -25.0% |
| Q1 2021 | $6,635,000 | +182.5% | 164,800 | +314.8% | 0.00% | +300.0% |
| Q4 2020 | $2,349,000 | -68.5% | 39,733 | -74.1% | 0.00% | -80.0% |
| Q3 2020 | $7,457,000 | +234.8% | 153,334 | +233.2% | 0.01% | +150.0% |
| Q2 2020 | $2,227,000 | -80.2% | 46,025 | -88.7% | 0.00% | -80.0% |
| Q1 2020 | $11,270,000 | +1669.2% | 405,703 | +1797.8% | 0.01% | – |
| Q4 2019 | $637,000 | +171.1% | 21,377 | +180.3% | 0.00% | – |
| Q3 2019 | $235,000 | – | 7,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |